Eicosapentaenoic acid (EPA) is a key anti-inflammatory/anti-aggregatory long-chain
polyunsaturated omega-3 fatty acid. Conversely, the omega-6 fatty acid, arachidonic acid …

Atherosclerosis is a chronic inflammatory disease affecting large and medium arteries and is
considered to be a major underlying cause of cardiovascular disease (CVD). Although the …

Micro-algae synthesize high levels of lipids, carbohydrates and proteins
photoautotrophically, thus attracting considerable interest for the biotechnological …

Background: Peripheral artery disease (PAD) is an athero-occlusive disease and a known
risk factor for cardiovascular events. The controlling nutritional status (CONUT) score and …

Background Omega-6 polyunsaturated fatty acids (omega-6 PUFA) are recommended in
European cardiovascular prevention guidelines. However, individual fatty acids have distinct …

Background The aim was to evaluate the significance of arteriosclerosis obliterans-related
biomarkers in patients with type 2 diabetes mellitus (T2DM), and to compare the effects of …

Background Research suggests omega-3 polyunsaturated fatty acids (PUFAs) exert
favorable effects on several biological processes involved in the development and …

Peripheral artery disease (PAD) is an atherosclerotic disease impacting over 200 million
individuals and the prevalence increases with age. PAD occurs when plaque builds up …

Recent studies showed that a low ratio between the levels of eicosapentaenoic acid and
those of arachidonic acid (EPA/AA) is associated with higher incidence of coronary artery …

Atherosclerosis is associated with various cardiovascular diseases (CVDs). Measurement of
arterial stiffness using pulse wave velocity (PWV) enables assessment of atherosclerosis …